More importantly, they demonstrated that pharmacological inhibition of GAG biosynthesis potentiates the internalisation and the cytotoxic activity of an antibody-drug conjugate targeting CA IX, disclosing important scenarios for the future development of targeted cancer treatments. The gene discussed is CA9; the disease is cancer.